NDC 51662-1457

DILTIAZEM HCI

Diltiazem Hci

DILTIAZEM HCI is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Diltiazem Hydrochloride.

• Product ID: 51662-1457_99c5813f-1fff-0eaa-e053-2a95a90a751b
• NDC: 51662-1457
• Product Type: Human Prescription Drug
• Proprietary Name: DILTIAZEM HCI
• Generic Name: Diltiazem Hci
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2019-12-15
• Marketing Category: ANDA / ANDA
• Application Number: ANDA075853
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: DILTIAZEM HYDROCHLORIDE
• Active Ingredient Strength: 100 mg/1
• Pharm Classes: Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 51662-1457-1

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (51662-1457-1)

• Marketing Start Date: 2019-12-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1457-1 [51662145701]

DILTIAZEM HCI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA075853
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-12-15

Drug Details

Active Ingredients

Ingredient	Strength
DILTIAZEM HYDROCHLORIDE	100 mg/1

Pharmacological Class

• Calcium Channel Antagonists [MoA]
• Calcium Channel Blocker [EPC]

NDC Crossover Matching brand name "DILTIAZEM HCI" or generic name "Diltiazem Hci"

NDC	Brand Name	Generic Name
51662-1335	DILTIAZEM HCI	DILTIAZEM HCI
51662-1457	DILTIAZEM HCI	DILTIAZEM HCI